H.C. Wainwright Reaffirms a “Buy” Rating on Ampliphi Biosciences (APHB) and $5.0 Target; Mantech International Class A (MANT) Sellers Decreased By 12.1% Their Shorts

November 15, 2017 - By Vivian Park

It closed at $0.86 lastly. It is down 94.86% since November 15, 2016 and is downtrending. It has underperformed by 111.56% the S&P500.

Mantech International Corporation Class A (NASDAQ:MANT) had a decrease of 12.1% in short interest. MANT’s SI was 454,800 shares in November as released by FINRA. Its down 12.1% from 517,400 shares previously. With 114,500 avg volume, 4 days are for Mantech International Corporation Class A (NASDAQ:MANT)’s short sellers to cover MANT’s short positions. The SI to Mantech International Corporation Class A’s float is 1.79%. It closed at $48.53 lastly. It is down 12.61% since November 15, 2016 and is uptrending. It has underperformed by 4.09% the S&P500.

AmpliPhi Biosciences Corporation is a biotechnology company. The company has market cap of $7.52 million. The Firm is focused on the discovery, development and commercialization of phage therapeutics. It currently has negative earnings. The Firm is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Among 9 analysts covering Mantech International Corporation (NASDAQ:MANT), 3 have Buy rating, 3 Sell and 3 Hold. Therefore 33% are positive. Mantech International Corporation had 25 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was initiated by Drexel Hamilton with “Hold” on Wednesday, November 16. The firm has “Hold” rating given on Thursday, November 2 by Noble Financial. Credit Suisse upgraded Mantech International Corp (NASDAQ:MANT) rating on Thursday, April 28. Credit Suisse has “Neutral” rating and $34 target. The stock of Mantech International Corp (NASDAQ:MANT) has “Underperform” rating given on Thursday, September 29 by Credit Suisse. The stock of Mantech International Corp (NASDAQ:MANT) earned “Underperform” rating by Jefferies on Wednesday, January 20. On Wednesday, September 20 the stock rating was maintained by Maxim Group with “Buy”. The stock has “Buy” rating by Loop Capital on Thursday, November 2. The firm has “Buy” rating by Maxim Group given on Thursday, November 2. As per Wednesday, November 30, the company rating was downgraded by Maxim Group. The rating was maintained by Jefferies on Thursday, August 17 with “Sell”.

ManTech International Corporation provides technologies and solutions for national security programs for the intelligence community; the departments of Defense, State, Homeland Security, Health and Human Services, Veteran Affairs and Justice, including the Federal Bureau of Investigation ; the space community, and other the United States Government customers. The company has market cap of $1.89 billion. It delivers an array of information technology (IT) and technical services solutions. It has a 31.81 P/E ratio. The Company’s solutions and services include cybersecurity; software and systems development; enterprise IT; multi-disciplined intelligence; command, control, communications, computers, intelligence, surveillance and reconnaissance; program protection and mission assurance; systems engineering; supply chain management and logistics; test and evaluation; training, and management consulting.

Investors sentiment increased to 2.02 in Q2 2017. Its up 0.60, from 1.42 in 2017Q1. It increased, as 6 investors sold Mantech International Corp shares while 37 reduced holdings. 28 funds opened positions while 59 raised stakes. 21.74 million shares or 0.09% more from 21.72 million shares in 2017Q1 were reported. Blackrock accumulated 0.01% or 3.96M shares. Art Ltd Liability Com reported 26,007 shares stake. Los Angeles Cap Mgmt Equity holds 6,335 shares. Louisiana State Employees Retirement System accumulated 10,400 shares or 0.02% of the stock. Chevy Chase Holdg Inc owns 0% invested in Mantech International Corp (NASDAQ:MANT) for 21,325 shares. Envestnet Asset Mngmt stated it has 0% in Mantech International Corp (NASDAQ:MANT). D E Shaw & Inc stated it has 0% of its portfolio in Mantech International Corp (NASDAQ:MANT). Robeco Institutional Asset Management Bv reported 47,271 shares. Advisory Services Network Limited Liability Company reported 0% of its portfolio in Mantech International Corp (NASDAQ:MANT). Bankshares Of Montreal Can owns 2,353 shares or 0% of their US portfolio. Sheets Smith Wealth Management holds 6,545 shares. Qs Invsts Limited Co holds 0% or 1,763 shares in its portfolio. Connable Office Inc accumulated 6,196 shares. Panagora Asset Mngmt Inc reported 0% of its portfolio in Mantech International Corp (NASDAQ:MANT). Deutsche Bancshares Ag invested in 151,446 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By : XYZScripts.com